Abstract
A broad spectrum of autoantibodies can be demonstrated in the serum of SLE patients. It was the observation by several investigators back in 1957 that there may exist a reaction between DNA and SLE sera [1–4] that started the serological studies of this disease. The earliest techniques used for detection of anti-dsDNA were relatively insensitive precipitation methods such as complement fixation and hemagglutination. At this moment specific and sensitive assays like radio immunoassay (RIA), immunofluorescence test on Crithidia luciliae (IFT) and enzyme linked immunosorbent assay (ELISA) are available for detecting and quantitating antibodies to DNA.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Refference
Seligmann M (1957) Vox Sang 2: 270–282
Ceppelini R, Polli E & Celada F (1957) Proc Soc Exp Biol (NY) 96: 572–574
Miescher P & Straessle R (1957) Vox Sang (Basel) 2: 283–287
Robbins WC, Holman HR, Deicher HR & Kunkel HG (1957) Proc Soc Exp Biol (NY) 96: 575–577
Stollar BD (1981) Clin Immunol All 1: 243–260
Swaak AJG, Groenwold J, Aarden LA & Feltkamp TEW (1981) Ann Rheum Dis 40: 45–49
Swaak AJG & Smeenk R (1985) Ann Rheum Dis 44: 245–251
Cohen AS, Reynolds WE & Franklin EC (1971) Bull Rheum Dis 21: 643–648
Tan EM, Cohen AS & Fries JF (1982) Arthritis Rheum 25: 1271–1277
Wold RT, Young FF, Tan EM & Farr RS (1968) Science 161: 806–807
Aarden LA, Lakmaker F & Feltkamp TEW (1976) J Immunol Meth 10: 39–48
Aarden LA & Smeenk R (1982) In: Kalden JR & Feltkamp TEW (Eds) Antibodies to Nuclear Antigens, pp. 23–28. Exerpa Medica, Amsterdam
Riley RL, McGrath TT & Taylor RP (1979) Arthritis Rheum 22: 219–225
Smeenk R & Aarden LA (1980) J Immunol Meth 39: 165–180
Aarden LA & Smeenk R (1981) In: Lefkovits & Pernis B (Eds) Immunological Methods, Vol II, pp. 75–82. Academic Press. New York
Smeenk R (1986) In: Pal SB (Ed) Immunoassay Technology, Vol II, pp. 145–166. De Gruyter, Berlin/New York
Emlen W, Jarusiripipat P & Burdick G (1990) J Immunol Meth 132: 91–98
Hylkema MN, Huygen H, Kramers C, Van der Wal ThJ, De Jong J, Van Bruggen MCJ, Swaak AJG, Berden JHM & Smeenk RJT (1994) J Immunol Meth 170: 93–102
Smeenk RJT, Van den Brink AG, Brinkman K, Termaat RM, Berden JHM & Swaak AJG (1991) Rheum Int 11: 101–107
Smeenk RJT & Hylkema M (1992) Mol Biol Rep 17: 71–79
Hasselbacher P & Leroy EC (1974) Arthritis Rheum 17: 63–71
Davis P, Atkins B & Hughes GRV (1974) Br J Dermatol 91: 175–181
Bell C, Talal N & Schur P (1975) Arthritis Rheum 18: 535–545
Jain S, Markham R, Thomas HC & Sherlock S (1976) Clin Exp Immunol 26: 35–41
Aarden LA (1977) Ann Rheum Dis 36 (Suppl): 91–95
Isenberg DA, Colaco CB, Dudeney C, Todd-Pokropek A & Snaith ML (1986) Medicine (Bathmore) 65: 46–55
Pincus T, Schur PH, Rose JA, Decker JL & Talal N (1969) N Engl J Med 281: 701–705
Davis P, Percy JS & Rusell AS (1977) Ann Rheum Dis 36: 157–159
Huhges GRV, Cohen SA & Christian CL (1971) Ann Rheum Dis 30: 259–264
Isenberg DA, Shoenfeld Y & Schwartz RJ (1984) Arthritis Rheum 27: 132–138
Gladman DD, Urowitz MB & Keystone EC (1975) Am J Med 66: 210–215
Swaak AJG, Aarden LA, Statius van Eps LW & Feltkamp TEW (1979) Arthritis Rheum 22: 226–235
Swaak AJG, Groenwold J, Aarden LA, Statius van Eps LW & Feltkamp TEW (1982) Ann Rheum Dis 41: 388–395
Ter Borg EJ, Horst G, Hummel EJ, Limburg PC & Kallenberg CGM (1990) Arthritis Rheum 33: 634–643
Ter Borg EJ, Horst G, Limburg PC & Kallenberg CGM (1990) Clin Exp Immunol 82: 21–26
Nossent JC, Huygen V, Smeenk RJT & Swaak AJG (1989) Ann Rheum Dis 48: 677–682
Reinertsen JL, Klippel JH, Steinberg AD, Decker JL & Mann DL (1978) N Engl J Med 299: 515–518
Smolen JS, Klippel JH & Penner E (1987) Ann Rheum Dis 46: 457–462
Sherak O, Smolen JS & Mayr WR (1980) Arthritis Rheum 23: 954–957
Celada A, Barras C, Benzonana G & Jeannet M (1980) Tissue Antigens 15: 283–288
Bell DA & Maddison PJ (1980) Arthritis Rheum 23: 1268–1273
Andonopoulos AP, Papasteriades CA, Drosos AA, Dimou GS & Moutsopoulos HM (1990) Clin Exp Rheumatol 8: 47–50
Reveille JD, Anderson KL, Schrohenloher RE, Acto RT & Barger BO (1991) J Rheumatol 18: 14–18
Swaak AJG & Smeenk RIT (1985) In: Peeters H (Ed) Protides of the Biological Fluids, 33th Ed, pp. 317–320. Pergamon Press, London
RJT Smeenk, Van Rooyen A & Swaak AJG (1988) J Immunol Meth 109: 27–35
De Groot ER, Lamers MC, Aarden LA, Smeenk RJT & Van Oss CJ (1980) Immunol Comm 9: 515–528
Smeenk RJT, Aarden LA & Van Oss CJ (1983) Immunol Comm 12: 177–183
Van Oss CJ, Smeenk RJT & Aarden LA (1985) Immunol Invest 14: 245–248
Swaak AJG, Huysen V, Nossent JC & Smeenk RJT (1990) Clin Rheumatol 9 (Suppl I): 82–95
Ter Borg EJ, Horst G, Limburg PC & Kallenberg CGM (1991) J Autoimmunity 4: 155–164
Van Dam AP, Nossent JC, Meilof JF, Ter Borg EJ, Swaak AJG & Smeenk RJT (1991) J Rheumatol 18: 1026–1034
Ward MM, Dooley MA, Christenson VD & Pisetsky DS (1991) J Rheumatol 18: 235 240
Spronk PE, Ter Borg EJ, Huitema MG, Limburg PC & Kallenberg CGM (1994) Ann Rheum Dis 53: 235–239
Beaulieu A, Quismorio FK & Friou G (1979) Arthritis Rheum 22: 565–570
Ballou SP & Kushner I (1979) Clin Exp Immunol 37: 58–67
Herrera Ezparza R, Swaak AJG, Aarden LA & Smeenk RJT (1985) J Rheumatol 12: 1190–1117
Koffler D, Agnello V, Thoburn R & Kunkel HG (1971) J Clin Invest 134: 1695–1795
Izui S, Lambert PH & Miescher PA (1977) Clin Exp Immunol 30: 384–392
Hahn BH (1982) Arthritis Rheum 25: 747–752
Dang H & Harbeck RJ (1984) Clin Immunol Immunopathol 30: 265–270
Faaber P, Capel PJA, Rijke GPM, Vierwinden G, Van de Putte LBA & Koene RAP (1984) Clin Exp Immunol 55: 502–508
Faaber P, Rijke GPM, Van de Putte LBA, Capel PJA & Berden JHM (1986) J Clin Invest 77: 1824–1830
Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Schwartz RS & Stollar DB (1981) J Exp Med 153: 897–909
Shoenfeld Y, Rauch J, Massicotte M, Stollar BD & Schwartz RS (1983) N Engl J Med 308: 414–420
Faaber P, Rijke GPM, Smeenk RJT, Capel PJA, Van de Putte LBA & Berden JHM (1985) In: Peeters H (Ed) Protides of the Biological Fluids, 33th Ed, p. 405. Pergamon Press, London
Faaber P, Rijke GPM, Van de Putte LBA, Capel PJA & Berden JHM (1986) J Clin Invest 77: 1824–1830
Termaat RM, Brinkman K, Nossent JC, Swaak AJG, Smeenk RIT & Berden JHM (1990) Clin Exp Immunol 82: 268–274
Termaat RM, Brinkman K, Van Gompel F, Van Heuvel LPWJ, Veerkamp J, Smeenk RJT & Berden JHM (1990) J Autoimmunity 3: 531–545
Brinkman K, Termaat RM, Berden JHM & Smeenk RJT (1990) Immunol Today 11: 232–234
Kramers C, Hylkema M, Termaat RM, Brinkman K, Smeenk R & Berden J (1993) Exp Nephrol 1: 224–228
Kramers C, Hylkema MN, Van Bruggen MCI, Van de Lagemaat R, Dijkman HBPM, Assmann KIM, Smeenk RJT & Berden JHM (1994) J Clin Invest 94: 568–577
Hylkema MN, Kramers C, Van der Wal ThJ, Van Bruggen MCJ, Swaak AJG, Berden JHM & Smeenk RIT (1994) J Immunol Meth 176: 33–43
Mohan C, Adams S, Stanik V & Datta SK (1993) J Exp Med 177: 1367–1381
Burlingame RW, Boey ML, Starkebaum G & Rubin RL (1994) J Clin Invest 94: 184–194
Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF & Jacob L (1994) Arthritis Rheum 37: 1684–1688
Swaak AJG, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L & Smeenk RJT (1989) Ann Rheum Dis 48: 447–454
Swaak AJG, Nossent JC, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L & Smeenk RJT (1989) Ann Rheum Dis 48: 455–460
Austin HA III, Klippel JH & Balow JE (1986) N Engl J Med 314: 614–619
Donadio IV Jr & Glassock RJ (1993) Am J Kidney Dis 21: 239–250
Appel AE, Sablay LB, Golden RA Grayzel AI & Bank N (1978) Am J Med 64: 274–283
Jarrett MP, Sablay LB, Walter L, Barland P & Grayzel AI (1981) Am J Med 70: 1067–1072
Bootsma H, Spronk PE, Limburg PC. Gmelig-Meyling FHJ, Kater L, Derksen RHWM & Kallenberg CGM (1995) (submitted for publication)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Swaak, A.J.G., Smeenk, R.J.T. (1996). Clinical aspects of antibodies to double-stranded DNA. In: van Venrooij, W.J., Maini, R.N. (eds) Manual of Biological Markers of Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1670-1_38
Download citation
DOI: https://doi.org/10.1007/978-94-011-1670-1_38
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-2219-1
Online ISBN: 978-94-011-1670-1
eBook Packages: Springer Book Archive